Your browser doesn't support javascript.
loading
Oral semaglutide for type 2 diabetes: A systematic review and meta-analysis.
Avgerinos, Ioannis; Michailidis, Theodoros; Liakos, Aris; Karagiannis, Thomas; Matthews, David R; Tsapas, Apostolos; Bekiari, Eleni.
Afiliação
  • Avgerinos I; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Michailidis T; Diabetes Centre, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Liakos A; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Karagiannis T; Diabetes Centre, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Matthews DR; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Tsapas A; Diabetes Centre, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Bekiari E; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Diabetes Obes Metab ; 22(3): 335-345, 2020 03.
Article em En | MEDLINE | ID: mdl-31637820

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Peptídeos Semelhantes ao Glucagon Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Peptídeos Semelhantes ao Glucagon Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article